[May 5th Webinar] Introduction of utilization cases of disease network analysis by natural language processing AI

Top > Event / Seminar, natural language AI

2023/5/12

FRONTEO's "Drug Discovery AI Factory" is a drug discovery support service that analyzes information and makes proposals that contribute to the efficiency, acceleration, and success rate of customers' drug discovery research using unique methods.We propose target molecules, biomarkers, MoA, new indications, etc. according to the customer's order in a much shorter period of time than conventional research methods, and submit a report that clearly states the basis for the proposal.

This time, based on a huge amount of paper information, we have developed an AI program "KIBIT Cascade Eye" that can visualize and structure information on molecules and genes related to diseases to be analyzed in the form of a pathway map (path diagram showing relationships). Please give an example of how you have used it.

Click here for registration and seminar details:https://lifescience.fronteo.com/webinar20230526

【Webinar Summary】

◆ Theme: Introduction of utilization cases of disease network analysis by natural language AI

Date: May 2023, 5 (Friday) 26:12-00:13

◆ Recommended for people like this!

・ Those who work for a pharmaceutical company
・ Those who are considering improving the efficiency of the drug discovery process with AI
・ Those involved in drug discovery research

◆Participation conditions: Those who use the free address, those who are in the same industry as our company, and those whose affiliation is unknown are not allowed to apply.When accessing Zoom on the day, please enter your name and email address that you entered at the time of application in the entry field for Zoom participation.

Speakers/panelist:

Professor, Department of Clinical Pharmacology, Faculty of Medicine, University of Tokushima
Professor Keisuke Ishizawa

Associate Professor, Department of Clinical Pharmacology, Faculty of Medicine, University of Tokushima
Professor Mitsuhiro Goda

Moderator

General Manager, Life Science AI Business Division, FRONTEO, Inc.
Nobuya Nakano

Share this article

0
Facebook
Twitter

<To the previous article

To the next article>

Share this article

0
Facebook
Twitter

Articles in the same category

[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -

[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~

Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI

Parkinson's disease - Analyzing drug discovery targets using paper search AI

Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th

Searching for new targets for sporadic ALS using AI: Become friends with AI

[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response

[On-site seminar held on 3/19] Latest trends in AI and competition law - from a global perspective <Simultaneous interpretation and reception available>

[Webinar held on 3/5] Are you fully prepared for a series of information leaks?: Recommendation of mock training from a crisis management perspective